Nikos Tsoulos studied Biochemistry and graduated with honors from New York State University at Stony Brook. He has worked as a Biochemist at the research laboratory of Capital Genomics Inc. in Maryland at USA.
As CEO, Nikos Tsoulos has created GeneKor’s sales and marketing departments establishing a series of partnerships with international organizations (Oncotype DX, miRview Foundation One, Molecular Intelligence and PCA3).
He has also developed a network of collaborating laboratories in Europe, the Middle East and the Balkans providing molecular analyses focusing on low cost, high quality, reliability and rapid results.
Nikos Tsoulos has also been the Vice President of the Research Institute of Individualized Medicine for Cancer, a non-profit organization.